Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD
Digital Health Global
APRIL 16, 2024
– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduct U.S. and Canada – MONMOUTH JUNCTION, N.J.–(BUSINESS With input from the U.S.
Let's personalize your content